VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-2.98%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$251M
AUM Growth
-$19M
(-7%)
Cap. Flow
-$3.64M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41
Top Buys
| 1 |
The Mosaic Company
MOS
|
$900K |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$877K |
| 3 |
Enphase Energy
ENPH
|
$858K |
| 4 |
Gartner
IT
|
$732K |
| 5 |
Devon Energy
DVN
|
$727K |
Top Sells
| 1 |
L3Harris
LHX
|
$740K |
| 2 |
Cheniere Energy
CQP
|
$732K |
| 3 |
Agilent Technologies
A
|
$713K |
| 4 |
Copart
CPRT
|
$688K |
| 5 |
Equifax
EFX
|
$678K |
Sector Composition
| 1 | Healthcare | 18.83% |
| 2 | Real Estate | 17.55% |
| 3 | Materials | 12.77% |
| 4 | Financials | 9.88% |
| 5 | Energy | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Aurinia Pharmaceuticals
AUPH
$1.63B
| $187K | 0.07% |
24,920
+364
| +1% | +$2.73K |
|
|
BCYC
327
Bicycle Therapeutics
BCYC
$496M
| $186K | 0.07% |
8,009
+63
| +0.8% | +$1.46K |
|
328
OFS Capital
OFS
$117M
| $183K | 0.07% |
22,215
-2,527
| -10% | -$20.8K |
|
329
Precigen
PGEN
$1.3B
| $182K | 0.07% |
85,618
+618
| +0.7% | +$1.31K |
|
330
Recursion Pharmaceuticals
RXRX
$2.01B
| $179K | 0.07% |
16,847
+121
| +0.7% | +$1.29K |
|
331
Cassava Sciences
SAVA
$104M
| $178K | 0.07% |
4,267
+26
| +0.6% | +$1.09K |
|
332
ImmunityBio
IBRX
$2.27B
| $174K | 0.07% |
35,048
+249
| +0.7% | +$1.24K |
|
333
Edgewise Therapeutics
EWTX
$1.64B
| $172K | 0.07% |
17,469
+128
| +0.7% | +$1.26K |
|
334
C4 Therapeutics
CCCC
$194M
| $169K | 0.07% |
19,305
+136
| +0.7% | +$1.19K |
|
335
Immunovant
IMVT
$2.99B
| $169K | 0.07% |
30,367
+221
| +0.7% | +$1.23K |
|
336
Lyell Immunopharma
LYEL
$233M
| $169K | 0.07% |
1,156
+9
| +0.8% | +$1.32K |
|
337
RAPT Therapeutics
RAPT
$214M
| $169K | 0.07% |
877
+6
| +0.7% | +$1.16K |
|
338
Erasca
ERAS
$457M
| $168K | 0.07% |
21,487
+150
| +0.7% | +$1.17K |
|
339
Relay Therapeutics
RLAY
$710M
| $168K | 0.07% |
7,526
+50
| +0.7% | +$1.12K |
|
|
IGMS
340
DELISTED
IGM Biosciences
IGMS
| $166K | 0.07% |
7,319
+52
| +0.7% | +$1.18K |
|
|
AMRS
341
DELISTED
Amyris Inc.
AMRS
| $166K | 0.07% |
56,770
+411
| +0.7% | +$1.2K |
|
|
AGEN
342
Agenus
AGEN
$138M
| $165K | 0.07% |
4,094
+30
| +0.7% | +$1.21K |
|
343
TG Therapeutics
TGTX
$5.11B
| $161K | 0.06% |
27,135
+200
| +0.7% | +$1.19K |
|
344
Prelude Therapeutics
PRLD
$69.6M
| $160K | 0.06% |
24,180
+175
| +0.7% | +$1.16K |
|
345
Syndax Pharmaceuticals
SNDX
$1.47B
| $159K | 0.06% |
6,628
+44
| +0.7% | +$1.06K |
|
346
Kymera Therapeutics
KYMR
$3.11B
| $157K | 0.06% |
7,222
+51
| +0.7% | +$1.11K |
|
347
Rocket Pharmaceuticals
RCKT
$354M
| $157K | 0.06% |
9,860
+68
| +0.7% | +$1.08K |
|
348
Sangamo Therapeutics
SGMO
$165M
| $155K | 0.06% |
31,651
+227
| +0.7% | +$1.11K |
|
|
IMGN
349
DELISTED
Immunogen Inc
IMGN
| $155K | 0.06% |
32,341
+235
| +0.7% | +$1.13K |
|
|
DICE
350
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $153K | 0.06% |
7,540
+58
| +0.8% | +$1.18K |
|